Loading market data...

Barclays Lifts Strategy Inc. Price Target to $175, Keeps Overweight Rating

Barclays Lifts Strategy Inc. Price Target to $175, Keeps Overweight Rating

Barclays raised its price target on Strategy Inc. (MSTR) from $160 to $175 on Friday, October 9, 2026, while sticking with an Overweight rating on the stock. The adjustment came as the company's tokenized contract on Binance continues to stall at a dense resistance cluster, leaving traders to weigh the bank's more bullish valuation against a stubborn technical ceiling.

The numbers behind the call

The move is a straightforward markup. Barclays had previously set its target at $160. The new $175 figure represents roughly a 9% increase, and the Overweight rating signals the bank still expects the stock to outperform the broader market or its sector over the coming months. There's no hedging language in the adjustment — just a higher number and the same positive stance.

Strategy Inc. has become a proxy for institutional appetite for crypto-linked equities. When a major bank moves its target, it tends to ripple through trading desks that treat MSTR as a bellwether for the sector.

A tokenized contract stuck at resistance

On Binance, the tokenized MSTR contract is running into what traders describe as a dense resistance cluster. That's a zone on the chart where sell orders have piled up, making it hard for the price to push higher without a burst of buying volume. The contract has been stalling there, unable to break through.

Tokenized contracts like this one give traders exposure to MSTR's price movements without owning the underlying shares, and they trade around the clock on the exchange. When they stall, it often reflects broader hesitation — in this case, a market that hasn't fully bought into Barclays' rosier outlook.

Why the divergence matters

You've got two signals pointing in opposite directions. On one side, a bulge-bracket bank is telling clients the stock is worth more than it thought a day earlier. On the other, the tokenized market — which never sleeps and reacts in real time — is refusing to break out.

That gap isn't unusual. Analyst price targets are typically 12-month projections, while tokenized contracts track spot prices and short-term sentiment. But when the two disagree this visibly, it's worth watching which one gives first.

For now, the resistance cluster on Binance is the more immediate constraint. Until buyers absorb the supply sitting at that level, the tokenized contract will likely keep chopping sideways, regardless of what Barclays' models say.

What traders are watching

The next few sessions will show whether the Barclays upgrade acts as a catalyst or gets drowned out by technical selling. If the tokenized MSTR contract can clear its resistance zone, it would validate the bank's more aggressive target. If it can't, the stock could drift even as the fundamental case improves.

There's also the question of follow-through. Barclays isn't the only shop covering MSTR, and a single target hike rarely moves the needle on its own. But it does raise the bar for what other analysts might do next. If peers start revising their own numbers upward, the cumulative effect could be enough to push the tokenized contract through.

Until then, the standoff continues: a higher price target on one screen, a stalled chart on another. The market will decide which one it believes.